Advocating for a world where intellectual
property law serves the public interest.

African Platform on Access to Information

The Pan African Conference on Access to Information was held this month in Capetown, hosted by UNECSO, the African Union, the UN Special Rapporteur on Freedom of Expression, and the African Commission on Human and Peoples’ Rights. Over 200 delegates who signed the African Platform on Access to Information, which states that “access to information […]

USTR Seeks Comments on “Notorious Markets”

The office of the US Trade Representative has requested comments from interested parties on “Notorious Markets,” which include both physical markets and internet sites that distribute infringing content. This is the second year in which the USTR list of Notorious Markets is separate from the Special 301 Report. Comments are due by October 26, […]

UN High Level Meeting Debates TRIPS Flexibilities for Non Communicable Diseases

On September 19-20, the UN held a High Level Meeting to develop a global strategy to fight Non-Communicable Diseases (NCDs), “principally cardiovascular diseases, cancers, chronic respiratory diseases and diabetes.” A draft resolution was developed prior to the meeting for ratification and delivery to the UN General Assembly. The U.S. lobbied for the removal of references […]

Dilma advocates breaking drug patents during UN speech

Translation by Walter Britto of the Brazilian news article “Dilma defende quebra de patentes de medicamentos em discurso na ONU,” by Luciana Xavier, O Estado de S.Paulo newspaper: In her speech during the opening of United Nation’s (UN) Special Summit on Chronic Diseases, Brazilian president Dilma Roussef upheld patent-breaking for select drugs. The summit happened […]

Obama’s Deficit Plan Would Reduce Data Exclusivity for Biologics and Ban Pay-for-Delay Patent Settlements

The Obama administration’s proposal to reduce U.S. deficits contains two provisions dealing with intellectual property and healthcare. The proposal would reduce data exclusivity for biologic medicines to 7 years (from the current period of 12 years), and would “prohibit additional periods of exclusivity for brand biologics due minor changes in product formulations, a practice often […]

September 19, 2011

IP Enforcement Roundup Changes to Weekly “Roundup” Email Starting next week, this email will be renamed the “Infojustice Roundup.” The scope will be widened to include more current, positive developments of IP policy (while still including updates on efforts to strengthen IP enforcement), to include more content from others, and to make the email less […]